“…[ 19 ] TWEAK induces several nephritis-related inflammatory mediators, including Chemokine (C-C motif) ligand 5, Chemokine (C-X-C motif) ligand 10, and Vascular cell adhesion molecule-1, in the inflammatory cascade, which can cause downstream inflammatory response activation and further renal damage progression. [ 20 , 21 ] Several cross-sectional and longitudinal studies have mentioned that urinary TWEAK levels elevate in active LN patients compared with that of remission ones. [ 13 , 22 ] However, the combined utility of untimed uMCP-1 and uTWEAK still needs investigation.…”